Updated

Shares of major pharmaceutical companies including AbbVie, Eli Lilly and Gilead Sciences closed near all-time highs this week as the ongoing selloff in AI and technology stocks pushed investors toward perceived safer bets. The rotation highlights a broader defensive shift in portfolios amid growing unease about stretched AI valuations.